FIELD: chemistry.
SUBSTANCE: present invention relates to a compound which is [2-(4-chlorobenzyloxy)ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate. Said compound has muscarinic M3 receptor antagonist properties and are used in production of a medicinal agent for use in treating chronic obstructive pulmonary disease and asthma.
EFFECT: [2-(4-chlorobenzyloxy)ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate, having chemical and physical stability, with a long storage life.
9 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF MUSCARINE RECEPTOR ANTAGONIST AND BETA-2-ADRENORECEPTOR AGONIST | 2008 |
|
RU2460527C2 |
| AZOLE AND THIAZOLE DERIVATIVES AND USE THEREOF | 2006 |
|
RU2436779C2 |
| FABRICATION OF FILLED CONTAINER FOR INHALER | 2011 |
|
RU2562017C2 |
| INHALER WITH DISCRETE MOTION INTERACTING TO LID MOTION | 2009 |
|
RU2513154C2 |
| BETA-LACTAMASE INHIBITORS | 2013 |
|
RU2654692C2 |
| PYRAZOLO[1,5-a]PYRIMIDINE AND THIENO[3,2-b]PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK-4 | 2011 |
|
RU2604062C2 |
| BREATH-ACTUATED INHALER | 2009 |
|
RU2519384C2 |
| DELIVERY DEVICE AND METHOD FOR INCREASING POWDER SUPPLY INTO AIR FLOW | 2010 |
|
RU2536826C2 |
| DIAMIDE COMPOUNDS HAVING ACTIVITY OF MUSCARINIC RECEPTOR ANTAGONIST AND ACTIVITY OF β ADRENERGIC RECEPTOR AGONIST | 2010 |
|
RU2676686C2 |
| DIAMIDE COMPOUNDS POSSESSING MUSCARINIC ANTAGONIST ACTIVITY AND B2 ADRENERGIC RECEPTOR B2 AGONIST ACTIVITY | 2010 |
|
RU2543716C2 |
